Why should 1 gram of ceftriaxone monotherapy be considered as a therapeutic option in gonococcal sexually transmitted diseases?

Subjects

Subjects :

Administration, Intravenous
Azithromycin adverse effects
Azithromycin economics
Ceftriaxone economics
Ceftriaxone pharmacology
Drug Resistance, Bacterial
Europe
Gonorrhea economics
Humans
Practice Guidelines as Topic
Sexually Transmitted Diseases economics
United States
Ceftriaxone administration & dosage
Gonorrhea drug therapy
Sexually Transmitted Diseases drug therapy

Details

Language :

English

ISSN :

1469-0691

Volume :

22

Issue :

11

Database :

MEDLINE

Journal :

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Publication Type :

Academic Journal

Accession number :

27404364

Full Text :

https://doi.org/10.1016/j.cmi.2016.07.002